Elixir Energy Ltd (ASX:EXR, OTC:ELXPF) has begun mobilising equipment and personnel for a new seismic program in Queensland’s Taroom Trough, as the company continues to build momentum across its growing gas portfolio in the Bowen Basin.
The company said mobilisation of the seismic fleet for the Teelba 2D Seismic Campaign has commenced in partnership with contractor Terrex Seismic, with acquisition expected to begin within the next week and take roughly three weeks to complete.
AuMEGA Metals Ltd (ASX:AAM, TSX:AUM, OTCQB:AUMMF, FRA:FRA: MA30) has completed the first tranche of its previously announced upsized financing, securing fresh capital to accelerate exploration across its extensive gold projects in Newfoundland, Canada.
The company confirmed it has closed Tranche One of the brokered private placement, raising about C$5.35 million (~A$5.58 million) through the issue of 98.4 million premium flow-through units (PFT Units) priced at C$0.0544 per unit.
Analysts at Noble Capital Markets have welcomed recent developments at First Phosphate Corp. (CSE:PHOS, OTCQX:FRSPF, FRA:KD0, OTC:FPHOY), which they believe meaningfully reduce technical, funding, and capital markets risk as the company advances toward a feasibility study.
First Phosphate recently received conditional approval for up to C$16.7 million in non-repayable funding through Natural Resources Canada under the Global Partnerships Initiative.
BioHarvest Sciences Inc (NASDAQ:BHST, FRA:8MV0) said on Thursday that it has appointed former Israeli health ministry chief Hezi Levy to the board effective immediately.
David Tsur will step down from its board of directors after more than four years of service, the company said in a statement.
Bit Digital Inc (NASDAQ:BTBT) reported its monthly Ethereum treasury and staking metrics for February 2026, outlining the size and value of its digital asset holdings as well as staking activity during the period.
As of February 28, the company held about 155,434 Ethereum (ETH). Based on a closing ETH price of about $1,965 at the end of the month, the holdings had a market value of roughly $305.4 million.
Medicus Pharma (NASDAQ:MDCX) said on Thursday that its experimental microneedle-based therapy showed encouraging efficacy in a mid-stage clinical trial for treating Basal Cell Carcinoma, with the highest-dose group achieving 73% clinical clearance of lesions.
The Phase 2 randomized, double-blind, placebo-controlled study enrolled 90 patients with nodular basal cell carcinoma and evaluated two doses of the company’s doxorubicin microneedle array (D-MNA), a non-invasive treatment designed to deliver chemotherapy through the skin.
Nextech3D.AI (CSE:NTAR, OTCQX:NEXCF, FRA:1SS) announced that it has expanded its AI-powered event technology platform into additional event market segments and implemented price increases across select enterprise offerings as part of efforts to support revenue growth and move toward profitability.
Historically, Nextech3D.ai’s Map Dynamics platform focused primarily on indoor trade shows and convention-center-based events. The company said it has now extended the platform into additional structured event verticals, including outdoor fairs and expos, music and food festivals, public and municipal events, multi-venue experiential activations, and seasonal or community-based events.
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5), the biotechnology company focused on gene therapies for age-related diseases, confirmed it has successfully raised £800,000 through a share subscription intended to advance its scientific programmes and strengthen its negotiating position for potential licensing deals.
The company has issued shares at 1.9p each, with each share accompanied by a warrant to subscribe for one additional stock at the same price within two years of issue.
Helium One Global Ltd (AIM:HE1, OTCQB:HLOGF, FRA:9K3) has told investors that its Galactica helium project in Colorado has reached a significant commercial milestone, after the operator reported the processing plant is now loading refined helium into a tube trailer for sale under spot-market arrangements.
The AIM-listed helium explorer, which holds a 50% working interest in the Galactica-Pegasus development project, said Blue Star Helium has commissioned the plant’s amine unit to remove CO₂ from the inlet gas stream.